Chennai Meenakshi Multispeciality Hospital Reports Negative Financial Results for Q3 2024
Chennai Meenakshi Multispeciality Hospital, a microcap company in the hospital and healthcare services industry, has declared its financial results for the quarter ending September 2024. The company has seen a negative performance with a 'Strong Sell' recommendation by MarketsMojo. While the Debtors Turnover Ratio has improved, there are concerns about declining cash flow, sales, and profitability.
Chennai Meenakshi Multispeciality Hospital, a microcap company in the hospital and healthcare services industry, has recently declared its financial results for the quarter ending September 2024. The stock call for the company by MarketsMOJO is 'Strong Sell'.
According to the financials, Chennai Meena has seen a negative performance in the quarter, with a score of -10 compared to -2 in the previous quarter. However, there are some positive aspects to the company's financials. The Debtors Turnover Ratio for the half-yearly period is the highest at 61.76 times and has grown consistently in the last five half-yearly periods. This indicates that the company has been able to settle its debtors faster.
On the other hand, there are some areas of concern for Chennai Meena. The Operating Cash Flow for the year has been the lowest at Rs 2.09 crore and has fallen each year in the last three years. This suggests that the company's cash revenues from business operations are declining. The Net Sales for the quarter have also fallen by -14.8% compared to the average of the previous four quarters. This indicates a negative trend in the company's sales in the near term.
Furthermore, the Operating Profit (PBDIT) for the quarter has been the lowest at Rs -0.24 crore in the last five quarters, and the Operating Profit Margin has also decreased to -2.97%. This shows a decline in the company's efficiency. The Profit Before Tax less Other Income (PBT) for the quarter has also been the lowest at Rs -0.77 crore in the last five quarters, indicating a negative trend in the near term. The Earnings per Share (EPS) for the quarter have also decreased to Rs -0.90, showing a decline in profitability and lower earnings for shareholders.
In conclusion, Chennai Meenakshi Multispeciality Hospital's financial performance for the quarter ending September 2024 has been negative, with a 'Strong Sell' recommendation by MarketsMOJO. While there are some positive aspects to the company's financials, there are also areas of concern that need to be addressed for the company to improve its performance in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
